Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Ugeskrift for Laeger|May 14, 2015
[New disease markers within the chronic myeloproliferative neoplasms]Morten Orebo Holmström, Lukas Frans Ocias, Klaus Kallenbach, et al.
Blood|March 13, 2009
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conferenceGiovanni Barosi, Gunnar Birgegard, Guido Finazzi, et al.
Plos One|September 1, 2017
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer developmentMorten Andersen, Zamra Sajid, Rasmus K Pedersen, et al.
Frontiers in Immunology|September 4, 2023
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrowMorten Orebo Holmström, Morten Andersen, Sofie Traynor, et al.
British Journal of Haematology|August 20, 2024
The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated plateletsMorten Orebo Holmström, Josephine Hallundbæk Ruders, Caroline Hasselbalch Riley, et al.
International Journal of Molecular Sciences|March 14, 2026
C282Y Homozygosity Increases Erythrocyte Turnover and Decreases HbA1c-A Population-Based StudyRebekka Hillingsø, Alisa Devedzic Kjaergaard, Morten Kranker Larsen, et al.
Scientific Reports|July 30, 2017
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutationsHelene Myrtue Nielsen, Christen Lykkegaard Andersen, Maj Westman, et al.
Blood Advances|May 17, 2024
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control studyDaniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, et al.
Scientific Reports|November 22, 2018
Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutationsHelene Myrtue Nielsen, Christen Lykkegaard Andersen, Maj Westman, et al.
Ugeskrift for Laeger|May 14, 2015
[Status and perspectives on chronic myeloproliferative neoplasm treatment]Lukas Frans Ocias, Morten Orebo Holmström, Caroline Hasselbalch Riley, et al.
Pageof 16